- Posted November 06, 2013
- Tweet This | Share on Facebook
Michigan claims $42M of $2.2B drug settlement
LANSING (AP) -- Michigan will get $42 million as part of a $2.2 billion national settlement with Johnson & Johnson over allegations that the company promoted powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients.
State Attorney General Bill Schuette said Monday that most of the money will go back to Michigan's Medicaid program.
Justice Department officials say Johnson & Johnson used illegal marketing tactics and kickbacks to persuade physicians and pharmacists to prescribe the antipsychotic drugs Risperdal and Invega and the heart failure drug Natrecor.
While doctors are allowed to prescribe medicines for any use, drugmakers can't promote them in any way that the U.S. Food and Drug Administration hasn't approved.
Published: Wed, Nov 6, 2013
headlines Oakland County
- Judge’s memorial unveiled
- Bring ’em to Ingham? Not necessarily, Supreme Court rules of lawsuits state files
- Nessel secures preliminary injunction protecting USDA funding
- Final judgment secured in lawsuit challenging administration’s $100k tax for H-1B visas
- Woman sentenced for distributing child porn, prosecutor disappointed with sentence imposed
headlines National
- Bill Kurtis’ memoir tells how law school trained him for covering trials
- ACLU and BigLaw firm use ‘Orange is the New Black’ in hashtag effort to promote NY jail reform
- Justice Barrett’s home targeted in attempted swatting call
- Texting-and-driving charges dropped against woman without right hand
- Fender warns guitar makers to stop producing Stratocaster look-a-likes
- General counsel compensation climbs, aligned with equity and company scale
